A phase II study of sequential combination chemotherapy with cyclophosphamide, prednisone, and 2-chlorodeoxyadenosine in previously untreated patients with chronic lymphocytic leukemia
Open Access
- 26 July 2001
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 15 (8) , 1171-1175
- https://doi.org/10.1038/sj.leu.2402172
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Chronic Lymphocytic LeukemiaPublished by Elsevier ,2002
- Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2000
- Phase I/II study of 2-chloro-2′-deoxyadenosine with cyclophosphamide in patients with pretreated B cell chronic lymphocytic leukemia and indolent non-Hodgkin's lymphomaLeukemia, 2000
- Cladribine with or without prednisone in the treatment of previously treated and untreated B‐cell chronic lymphocytic leukaemia — updated results of the multicentre study of 378 patientsBritish Journal of Haematology, 2000
- Long‐term clinical outcome of B‐cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic levelBritish Journal of Haematology, 1997
- Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemiaThe Lancet, 1996
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Confidence Intervals for a Binomial Parameter Based on Multistage TestsBiometrics, 1987
- Incorporation of 9-β-d-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNABiochemical Pharmacology, 1986
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958